JPH07506366A - 経口懸濁製剤用の安定な水和セファロスポリン乾燥粉末 - Google Patents
経口懸濁製剤用の安定な水和セファロスポリン乾燥粉末Info
- Publication number
- JPH07506366A JPH07506366A JP5519413A JP51941393A JPH07506366A JP H07506366 A JPH07506366 A JP H07506366A JP 5519413 A JP5519413 A JP 5519413A JP 51941393 A JP51941393 A JP 51941393A JP H07506366 A JPH07506366 A JP H07506366A
- Authority
- JP
- Japan
- Prior art keywords
- ceftibuten
- formulation
- hydrated
- water
- dry
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.空気酸化および脱水に耐性であり且つ経口投与しうる製品を生成するための 水中懸濁液に適している乾燥水和セファロスポリン粉末製剤の製造法であって、 周囲温度および湿度条件において、乾燥固体粉末状態の水和セファロスポリンま たはその薬学的に許容しうる塩を、非イオン性界面活性剤、沈殿防止剤、増粘剤 、不透明剤、保存剤および甘味剤から成る群より選択される実質的に乾燥した薬 学的に許容しうる賦形剤と混合して乾燥混合物を生成し、そのように生成された 乾燥混合物を、約5容量パーセント以下の酸素を含む雰囲気下において入射可視 線に対して不透明な密封可能貯蔵容器に入れることを含む上記方法。 2.水和セファロスポリンが、約7重量%〜約14重量%の水を含むセフチブテ ン三水和物である請求項1に記載の二水和物または方法。 3.適当な懸濁経口用剤形の薬剤組成物を生成するための、薬学的に許容しうる 担体を用いる構成に適した乾燥水和セフチブテン粉末製剤であって、(1)約7 重量%〜14重量%の水を含む、抗細菌性有効量の水和セフチブテン; (2)有効量の非イオン性界面活性剤;(3)有効量の消泡剤; (4)二酸化ケイ素と、ケイ酸マグネシウムアルミニウム、徴結晶性セルロース およびカルボキシメチルセルロースの6:1〜10:1(w/w)の比率の混合 物並びにキサンタンガムの少なくとも1種類とから成る群より選択される、懸濁 液を増粘させるのに有効な量の増粘剤;(5)有効量の不透明剤;および (6)一定量の甘味剤または甘味剤組成物を含む上記製剤。 4.水中の経口用懸濁剤形として用いるのに適した安定な乾燥水和セフチブテン 粉末製剤であって、 成分 mg/g(1)約7重量%〜約14重量% の 約65〜約150 水を含む水和セフチブテン (2)ポリソルベート80 約0.30〜約0.50(3)シメチコン 約0.60〜約1.0(4)キサンタンガム 約12〜約20(5)二酸化ケイ素 約8〜約12(6)二酸化 チタン 約14〜約22(7)水溶性保存剤 約 3〜約9(8)果実風味着香剤 約3〜約5および (9)甘味剤または甘味剤組成物 1gまでの十分な量を含む上記製剤。 5.成分が下記の量、 成分 mg/g(1)約7重量%〜 約14重量%の 72〜144 水を含む水和セフチブテン (2)ポリソルベート80 約0.4(3)シメチコン 約0.8(4)キサンタンガム 約16(5)二酸化ケイ素 約10(6 )二酸化チタン 約18(7)安息香酸ナトリウム 約4〜8(8)マイクロカプセル化された果実風味着香 剤 約3〜5および (9)甘味剤または甘味剤組成物 1gまでの十分な量で存在す る請求項4に記載の安定な乾燥水和セフチブテン粉末製剤。 6.抗細菌性有効量の請求項4に記載の製剤と、沈降に対して懸濁液が意外にも 長時間安定である製剤の水中懸濁液を生成するのに十分な量の滅菌水とを含む経 口投与に適した薬剤組成物。 7.甘味剤配合物がスクロースである請求項4に記載の製剤。 8.セフチブテン三水和物を用いる請求項4若しくは5に記載の乾燥水和セフチ ブテン粉末製剤または請求項6に記載の薬剤組成物。 9.セフチブテン二水和物を用いる請求項4若しくは5に記載の乾燥水和セフチ ブテン粉末製剤または請求項6に記載の薬剤組成物。 10.製剤が、約5容量%未満の酸素を含む雰囲気存在下において維持されてい る、請求項4若しくは5に記載の乾燥水和セフチブテン粉末製剤または請求項1 に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87688192A | 1992-04-30 | 1992-04-30 | |
US876,881 | 1992-04-30 | ||
PCT/US1993/003856 WO1993021923A1 (en) | 1992-04-30 | 1993-04-30 | Stable hydrated cephalosporin dry powder for oral suspension formulation |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07506366A true JPH07506366A (ja) | 1995-07-13 |
JP3378004B2 JP3378004B2 (ja) | 2003-02-17 |
Family
ID=25368763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51941393A Expired - Lifetime JP3378004B2 (ja) | 1992-04-30 | 1993-04-30 | 経口懸濁製剤用の安定な水和セファロスポリン乾燥粉末 |
Country Status (23)
Country | Link |
---|---|
US (1) | US5599557A (ja) |
EP (1) | EP0642344B1 (ja) |
JP (1) | JP3378004B2 (ja) |
KR (1) | KR100257803B1 (ja) |
AT (1) | ATE150310T1 (ja) |
AU (1) | AU674516B2 (ja) |
CA (1) | CA2134467A1 (ja) |
CZ (1) | CZ283428B6 (ja) |
DE (1) | DE69309052T2 (ja) |
DK (1) | DK0642344T3 (ja) |
EE (1) | EE03039B1 (ja) |
ES (1) | ES2099438T3 (ja) |
FI (1) | FI945081A0 (ja) |
GR (1) | GR3023516T3 (ja) |
HK (1) | HK1002407A1 (ja) |
HU (1) | HU215958B (ja) |
NO (1) | NO307594B1 (ja) |
NZ (1) | NZ252433A (ja) |
PL (1) | PL171630B1 (ja) |
RU (1) | RU2123863C1 (ja) |
SK (1) | SK279329B6 (ja) |
UA (1) | UA27899C2 (ja) |
WO (1) | WO1993021923A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009001786A1 (ja) * | 2007-06-22 | 2008-12-31 | Kaneka Corporation | 生理活性物質含有組成物 |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2079327B1 (es) * | 1994-12-13 | 1996-08-01 | Lilly Sa | Formulaciones farmaceuticas de cefaclor. |
US6565882B2 (en) * | 2000-02-24 | 2003-05-20 | Advancis Pharmaceutical Corp | Antibiotic composition with inhibitor |
US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
US6541014B2 (en) * | 2000-10-13 | 2003-04-01 | Advancis Pharmaceutical Corp. | Antiviral product, use and formulation thereof |
US20020068078A1 (en) * | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
US20020197314A1 (en) * | 2001-02-23 | 2002-12-26 | Rudnic Edward M. | Anti-fungal composition |
US7101573B2 (en) * | 2001-09-28 | 2006-09-05 | Mcneil-Pcc, Inc. | Simethicone solid oral dosage form |
WO2005009364A2 (en) * | 2003-07-21 | 2005-02-03 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
JP2006528189A (ja) * | 2003-07-21 | 2006-12-14 | アドバンシス ファーマスーティカル コーポレイション | 抗生物質産物、その使用法および製剤 |
EP1648407A4 (en) * | 2003-07-21 | 2011-08-31 | Middlebrook Pharmaceuticals Inc | ANTIBIOTIC PRODUCT, CORRESPONDING USE AND FORMULATION |
EP1653925A1 (en) * | 2003-08-11 | 2006-05-10 | Advancis Pharmaceutical Corporation | Robust pellet |
JP2007502294A (ja) | 2003-08-12 | 2007-02-08 | アドバンシス ファーマスーティカル コーポレイション | 抗生物質製剤、その使用法及び作成方法 |
EP1658034A4 (en) * | 2003-08-29 | 2011-06-22 | Middlebrook Pharmaceuticals Inc | ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION |
CA2538064C (en) * | 2003-09-15 | 2013-12-17 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
AU2004308419B2 (en) * | 2003-12-24 | 2011-06-02 | Victory Pharma, Inc. | Enhanced absorption of modified release dosage forms |
WO2006014427A1 (en) * | 2004-07-02 | 2006-02-09 | Advancis Pharmaceutical Corporation | Tablet for pulsed delivery |
US8653145B2 (en) * | 2005-09-22 | 2014-02-18 | Eaton Scientific Systems, Ltd. | Method for alleviating climacteric symptoms |
US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
US8778924B2 (en) * | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
US8299052B2 (en) | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
WO2008016678A2 (en) * | 2006-08-01 | 2008-02-07 | Sunesis Pharmaceuticals, Inc. | Pharmaceutical dosage forms for (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid |
FR2911506B1 (fr) * | 2007-01-18 | 2009-07-03 | Ceva Sante Animale Sa | Compositions pharmaceutiques destinees a une administration par voie orale sous forme de suspensions aqueuses stabilisees |
US8999395B2 (en) | 2007-02-09 | 2015-04-07 | Ceva Sante Animale | Pharmaceutical compositions for oral administration in the form of stabilised aqueous suspensions |
WO2009025277A1 (ja) * | 2007-08-22 | 2009-02-26 | Kaneka Corporation | 還元型補酵素q10の製造方法、ならびに、その安定化方法 |
EP2566449B1 (en) | 2010-05-04 | 2014-10-08 | Mahmut Bilgic | Pharmaceutical compositions comprising ceftibuten |
RU2550932C1 (ru) * | 2014-03-18 | 2015-05-20 | Александр Александрович Кролевец | Способ получения нанокапсул цефалоспориновых антибиотиков в ксантановой камеди |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3549746A (en) * | 1967-11-02 | 1970-12-22 | Bristol Myers Co | Antibiotic composition |
US3780195A (en) * | 1969-10-22 | 1973-12-18 | Balchem Corp | Encapsulation process |
US4016254A (en) * | 1972-05-19 | 1977-04-05 | Beecham Group Limited | Pharmaceutical formulations |
GB1561301A (en) * | 1976-01-02 | 1980-02-20 | Beecham Group Ltd | Orally administrable pharmaceutical composition |
US4321253A (en) * | 1980-08-22 | 1982-03-23 | Beatty Morgan L | Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration |
IE58110B1 (en) * | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
IT1183574B (it) * | 1985-05-08 | 1987-10-22 | Eurand Spa | Metodo per ottenere una sospensione estemporanea omogenea di microcapsule |
NZ220764A (en) * | 1986-07-02 | 1989-09-27 | Shionogi & Co | Crystalline form of 7beta((z)-2-(2-aminothiazol-4-yl)-4- carboxybut-2-enoylamino)-3-cephem-4-carboxylic acid and pharmaceutical compositions |
US4803082A (en) * | 1987-10-28 | 1989-02-07 | Warner-Lambert Company | Flavor and sweetness enhancement delivery systems and method of preparation |
US5112604A (en) * | 1989-09-01 | 1992-05-12 | Riker Laboratories, Inc. | Oral suspension formulation |
-
1993
- 1993-04-30 DK DK93910771.0T patent/DK0642344T3/da active
- 1993-04-30 PL PL93305809A patent/PL171630B1/pl unknown
- 1993-04-30 CA CA002134467A patent/CA2134467A1/en not_active Abandoned
- 1993-04-30 EP EP93910771A patent/EP0642344B1/en not_active Expired - Lifetime
- 1993-04-30 WO PCT/US1993/003856 patent/WO1993021923A1/en active IP Right Grant
- 1993-04-30 JP JP51941393A patent/JP3378004B2/ja not_active Expired - Lifetime
- 1993-04-30 AT AT93910771T patent/ATE150310T1/de not_active IP Right Cessation
- 1993-04-30 US US08/325,400 patent/US5599557A/en not_active Expired - Lifetime
- 1993-04-30 ES ES93910771T patent/ES2099438T3/es not_active Expired - Lifetime
- 1993-04-30 UA UA94119040A patent/UA27899C2/uk unknown
- 1993-04-30 SK SK1311-94A patent/SK279329B6/sk unknown
- 1993-04-30 RU RU94046038A patent/RU2123863C1/ru active
- 1993-04-30 DE DE69309052T patent/DE69309052T2/de not_active Expired - Lifetime
- 1993-04-30 NZ NZ252433A patent/NZ252433A/en unknown
- 1993-04-30 CZ CZ942636A patent/CZ283428B6/cs not_active IP Right Cessation
- 1993-04-30 HU HU9403108A patent/HU215958B/hu not_active IP Right Cessation
- 1993-04-30 AU AU41152/93A patent/AU674516B2/en not_active Ceased
-
1994
- 1994-10-28 NO NO944113A patent/NO307594B1/no not_active IP Right Cessation
- 1994-10-28 FI FI945081A patent/FI945081A0/fi unknown
- 1994-10-29 KR KR1019940703864A patent/KR100257803B1/ko not_active IP Right Cessation
- 1994-11-21 EE EE9400249A patent/EE03039B1/xx unknown
-
1997
- 1997-05-23 GR GR970401164T patent/GR3023516T3/el unknown
-
1998
- 1998-02-24 HK HK98101409A patent/HK1002407A1/xx not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009001786A1 (ja) * | 2007-06-22 | 2008-12-31 | Kaneka Corporation | 生理活性物質含有組成物 |
Also Published As
Publication number | Publication date |
---|---|
EE03039B1 (et) | 1997-10-15 |
GR3023516T3 (en) | 1997-08-29 |
ATE150310T1 (de) | 1997-04-15 |
HUT71226A (en) | 1995-11-28 |
PL171630B1 (pl) | 1997-05-30 |
CZ263694A3 (en) | 1995-04-12 |
NO307594B1 (no) | 2000-05-02 |
NO944113L (no) | 1994-10-28 |
SK131194A3 (en) | 1995-07-11 |
CZ283428B6 (cs) | 1998-04-15 |
DK0642344T3 (da) | 1997-07-07 |
JP3378004B2 (ja) | 2003-02-17 |
RU94046038A (ru) | 1996-11-10 |
HK1002407A1 (en) | 1998-08-21 |
AU4115293A (en) | 1993-11-29 |
FI945081A (fi) | 1994-10-28 |
NZ252433A (en) | 1996-07-26 |
RU2123863C1 (ru) | 1998-12-27 |
EP0642344B1 (en) | 1997-03-19 |
WO1993021923A1 (en) | 1993-11-11 |
FI945081A0 (fi) | 1994-10-28 |
KR950701224A (ko) | 1995-03-23 |
HU215958B (hu) | 1999-03-29 |
UA27899C2 (uk) | 2000-10-16 |
US5599557A (en) | 1997-02-04 |
HU9403108D0 (en) | 1995-02-28 |
CA2134467A1 (en) | 1993-11-11 |
NO944113D0 (no) | 1994-10-28 |
SK279329B6 (sk) | 1998-10-07 |
ES2099438T3 (es) | 1997-05-16 |
AU674516B2 (en) | 1997-01-02 |
DE69309052T2 (de) | 1997-06-19 |
EP0642344A1 (en) | 1995-03-15 |
DE69309052D1 (de) | 1997-04-24 |
KR100257803B1 (en) | 2000-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH07506366A (ja) | 経口懸濁製剤用の安定な水和セファロスポリン乾燥粉末 | |
JP4065321B2 (ja) | 水分活性を調節したゼラチンカプセル剤 | |
RU2241460C2 (ru) | Фармацевтическая композиция цефуроксим аксетила с маскированным горьким вкусом | |
JPH02286615A (ja) | 経口投与用イブプロフェン組成物 | |
RU2205639C2 (ru) | Фармацевтический суспензионный препарат, содержащий амоксициллин, клавулановую кислоту и целлюлозу | |
JP3480939B2 (ja) | アモキシシリンおよびクラブラン酸含有の組成物 | |
ES2524197T3 (es) | Gránulos y granulados recubiertos con sabor enmascarado | |
ES2234581T3 (es) | Suspension farmaceutica bebible de ibuprofeno. | |
JP2922456B2 (ja) | トリメブチンを含む新規医薬組成物及びその調製法 | |
JP4208759B2 (ja) | 安定なアジスロマイシン非二水和物経口懸濁剤 | |
US20040191326A1 (en) | Taste-masking vehicle for coated oxazolidinone particles | |
WO2004096175A2 (en) | Taste masked microcapsules and processes for their preparation | |
TW200400197A (en) | Pharmaceutical compositions of azithromycin | |
EP4331572A2 (en) | Pediatric suspension formulation | |
CZ11407U1 (cs) | Farmaceutický prostředek uzpůsobený pro pediatrické podávání | |
EP2882423A1 (en) | Uncoated tablet comprising granules including a -lactam antibiotic and highly dispersed silicone dioxide | |
SI20058A (sl) | Farmacevtske oblike | |
KR20000050265A (ko) | 아지스로마이신 경구 투여 제형을 포함하는 치료용 패키지 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20071206 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081206 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091206 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091206 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101206 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101206 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111206 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111206 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121206 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121206 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131206 Year of fee payment: 11 |
|
EXPY | Cancellation because of completion of term |